Status:
UNKNOWN
Intranasal Dexmedetomidine Versus Intravenous Dexmedetomidine for Improving Quality of Endoscopic Sinus Surgery
Lead Sponsor:
Kafrelsheikh University
Conditions:
Dexmedetomidine
Functional Endoscopic Sinus
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
compare intranasal dexmedetomidine versus intravenous dexmedetomidine for improving quality of the operative field in Functional endoscopic sinus surgery
Detailed Description
Functional endoscopic sinus surgery is a well-established therapeutic option for intractable CRS and other indications. Functional endoscopic sinus surgery is a minimally invasive procedure and is com...
Eligibility Criteria
Inclusion
- Patients underwent Functional Endoscopic Sinus Surgery
- American Society of Anesthesiologists (ASA) physical status classification I or II
Exclusion
- Patients with a body mass index \> 30 kg/m2 existing or recent significant disease
- contraindications to the use of dexmedetomidine
- history or presence of a significant disease significant cardiovascular disease risk factors
- significant coronary artery disease or any known genetic predisposition
- history of any kind of drug allergy
- drug abuse
- psychological or other emotional problems
- special diet or lifestyle
- clinically significant abnormal findings in physical examination, electrocardiographic (ECG) or laboratory screening
- known systemic disease requiring the use of anticoagulants, patients with a history of previous Functional Endoscopic Sinus Surgery
Key Trial Info
Start Date :
December 20 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 15 2023
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT06081933
Start Date
December 20 2022
End Date
December 15 2023
Last Update
October 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mohammad Fouad Algyar
Kafr ash Shaykh, Kafr El-Shaikh, Egypt, 33516